Rilzabrutinib for treating persistent or chronic immune thrombocytopenia in people aged 12 and over [ID6395]

  • In development
  • GID-TA11491
  • Expected publication date: TBC

NIHRIO BN: 30538-Rilzabrutinib-for-Immune-Thrombocytopenia-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)